Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell E Lewis

Showing results (11-20 of 225) with videos related to

Pageof 23
Sort By:
The Journal of Antimicrobial Chemotherapy|January 6, 2018
Overview of antifungal dosing in invasive candidiasisFederico Pea, Russell E Lewis
Journal of Fungi (Basel, Switzerland)|December 22, 2018
Development and Applications of Prognostic Risk Models in the Management of Invasive Mold DiseaseMarta Stanzani, Russell E Lewis
The Journal of Antimicrobial Chemotherapy|October 13, 2025
The long walk to a short half-life: the discovery of augmented renal clearance and its impact on antibiotic dosingJeffrey Lipman, Russell E Lewis
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 21, 2024
Primary antifungal prophylaxis after haematopoietic stem cell transplantation: will the search for perfection become the enemy of good?Russell E Lewis, Marta Stanzani
The New England Journal of Medicine|January 28, 2005
Caspofungin versus liposomal amphotericin B for empirical therapyDimitrios P Kontoyiannis, Russell E Lewis
Future Microbiology|September 12, 2013
Epidemiology and treatment of mucormycosisRussell E Lewis, Dimitrios P Kontoyiannis
Expert Opinion on Investigational Drugs|July 29, 2003
The echinocandin antifungals: an overview of the pharmacology, spectrum and clinical efficacyNathan P Wiederhold, Russell E Lewis
Current Opinion in Infectious Diseases|May 19, 2021
Managing uncertainty in antifungal dosing: antibiograms, therapeutic drug monitoring and drug-drug interactionsRussell E Lewis, David R Andes
British Journal of Haematology|July 9, 2004
Toward more effective antifungal therapy: the prospects of combination therapyDimitrios P Kontoyiannis, Russell E Lewis
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 14, 2020
Chimeric Antigen Receptor T-cell Immunotherapy and Need for Prophylaxis for Invasive Mold InfectionsRussell E Lewis, Dimitrios P Kontoyiannis
Pageof 23

Showing results (11-20 of 225) with videos related to

Sort By:
Pageof 23
The Journal of Antimicrobial Chemotherapy|January 6, 2018
Overview of antifungal dosing in invasive candidiasisFederico Pea, Russell E Lewis
Journal of Fungi (Basel, Switzerland)|December 22, 2018
Development and Applications of Prognostic Risk Models in the Management of Invasive Mold DiseaseMarta Stanzani, Russell E Lewis
The Journal of Antimicrobial Chemotherapy|October 13, 2025
The long walk to a short half-life: the discovery of augmented renal clearance and its impact on antibiotic dosingJeffrey Lipman, Russell E Lewis
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 21, 2024
Primary antifungal prophylaxis after haematopoietic stem cell transplantation: will the search for perfection become the enemy of good?Russell E Lewis, Marta Stanzani
The New England Journal of Medicine|January 28, 2005
Caspofungin versus liposomal amphotericin B for empirical therapyDimitrios P Kontoyiannis, Russell E Lewis
Future Microbiology|September 12, 2013
Epidemiology and treatment of mucormycosisRussell E Lewis, Dimitrios P Kontoyiannis
Expert Opinion on Investigational Drugs|July 29, 2003
The echinocandin antifungals: an overview of the pharmacology, spectrum and clinical efficacyNathan P Wiederhold, Russell E Lewis
Current Opinion in Infectious Diseases|May 19, 2021
Managing uncertainty in antifungal dosing: antibiograms, therapeutic drug monitoring and drug-drug interactionsRussell E Lewis, David R Andes
British Journal of Haematology|July 9, 2004
Toward more effective antifungal therapy: the prospects of combination therapyDimitrios P Kontoyiannis, Russell E Lewis
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 14, 2020
Chimeric Antigen Receptor T-cell Immunotherapy and Need for Prophylaxis for Invasive Mold InfectionsRussell E Lewis, Dimitrios P Kontoyiannis
Pageof 23